1c. Is Your Project an Investigative Project (aka PSS-Lite)?
No
1d. Is your Project Artifact being Reaffirmed or proceeding to Normative directly after being either Informative or STU?
No
1e. Today's Date
1f. Name of standard being reaffirmed
1g. Project Artifact Information
1h. ISO/IEC Standard to Adopt
1i. Does the standard include excerpted text from one or more ISO, IEC or ISO/IEC standards, but is not an identical or modified adoption?
1j. Unit of Measure
2a. Primary/Sponsor WG
Patient Care
2b. Co-Sponsor WG
Clinical Information Modeling Initiative
2c. Co-Sponsor Level of Involvement
Request formal content review prior to ballot
2b. Co-Sponsor WG 2
Electronic Health Record
2c. Co-Sponsor Level of Involvement
Request periodic project updates; specify period in text box below (e.g. 'Monthly', 'At WGMs', etc.)
2c. Co-Sponsor 2 Update Periods
Weekly as appropriate
2b. Co-Sponsor WG 3
Clinical Interoperability Council
2c. Co-Sponsor Level of Involvement
Request periodic project updates; specify period in text box below (e.g. 'Monthly', 'At WGMs', etc.)
2d. Project Facilitator
Susan Matney
2e. Other Interested Parties (and roles)
Michael Brody, DPM. CEO Registry Clearinghouse
2f. Modeling Facilitator
Nathan Davis
2g. Publishing Facilitator
Patrick Langford
2h. Vocabulary Facilitator
Susan Matney
2i. Domain Expert Representative
National Pressure Ulcer Advisory Panel
2j. Business Requirements Analyst
2k. Conformance Facilitator
2l. Other Facilitators
2m. Implementers
Tissue Analytics
Intermountain Heatlhcare
3a. Project Scope
To develop a skin and wound assessment model and FHIR profiles which can be used to document, track and trend wound care across settings.
This FHIR implementation guide will use the US Core profiles. If this FHIR implementation guide is unable to use a US Core profile we will request approval from US Realm SC, and provide the US Realm approved rationale for deviation in the implementation guide where applicable.
Attachments
3b. Project Need
Wound care is a clinical domain of high interest because iatrogenic skin and tissue breakdowns (e.g., pressure ulcers) and the mitigation of risk for skin breakdown are recognized as indicators of quality. The National Quality Forum endorsed pressure ulcers as a nursing sensitive outcome measure, and the Centers for Medicare and Medicaid Services (CMS) view hospital acquired pressure ulcers as a preventable hospital acquired condition for which hospitals no longer receive added reimbursement.
Wounds are also cared for across settings. Wounds are documented in three different apps within Intermountain Healthcare, one of which is Tissue Analytics - therefore, Intermountain would like to implement the FHIR profiles within their enterprise.
3c. Security Risk
No
3d. External Drivers
Veteran's Administration, National Pressure Ulcer Advisory Panel, Podiatrists
3e. Objectives/Deliverables and Target Dates
1. Develop the logical model (complete)
2. Curate the needed terminology content with LOINC and SNOMED CT (complete).
3. Test the FHIR profiles during a connectathon (Done in Montreal)
4. Create R4 FHIR profiles and IG - first draft done 1/31/2020
5. Enhance FHIR profile for implementers, including expanding body locations (in progress, target is 3/15/2020).
6. Develop the IG (target date 3/28/2020)
7. Connectathon - May 2021
8. Ballot in Sept 2021
3k. Additional Backwards Compatibility Information (if applicable)
3l. Using Current V3 Data Types?
N/A
3l. Reason for not using current V3 data types?
3m. External Vocabularies
Yes
3n. List of Vocabularies
SNOMED CT, SNOMED CT HSPC extension
LOINC
UCUM
3o. Earliest prior release and/or version to which the compatibility applies
4a. Products
FHIR Implementation Guide, FHIR Profiles
4b. For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to?
v4
4c. FHIR Profiles Version
4d. Please define your New Product Definition
4d. Please define your New Product Family
5a. Project Intent
Create new standard
5a. White Paper Type
5a. Is the project adopting/endorsing an externally developed IG?
5a. Externally developed IG is to be (select one)
5a. Specify external organization
5a. Revising Current Standard Info
5b. Project Ballot Type
STU to Normative
5c. Additional Ballot Info
https://github.com/HL7/fhir-skin-wound-ig
5d. Joint Copyright
Yes
5e. I understand I must submit a Joint Copyright Letter of Agreement to the TSC in order for the PSS to receive TSC approval.
Yes
6a. External Project Collaboration
National Pressure Ulcer Advisory Panel
Wound care nurses at the Veteran's administration as subject matter experts.
6b. Content Already Developed
90
6c. Content externally developed?
No
6d. List Developers of Externally Developed Content
Nursing Knowledge Big Data Science Initiative
Solor content developers (Keith Campbell, Susan Matney, et al.)
Intermountain Healthcare
Podiatrists
6e. Is this a hosted (externally funded) project?
No
6f. Stakeholders
Quality Reporting Agencies, Regulatory Agency, Standards Development Organizations (SDOs), Payors
6f. Other Stakeholders
6g. Vendors
EHR, PHR
6g. Other Vendors
6h. Providers
Emergency Services, Healthcare Institutions (hospitals, long term care, home care, mental health)
6h. Other Providers
6i. Realm
U.S. Realm Specific
7d. US Realm Approval Date
Feb 25, 2020
7a. Management Group(s) to Review PSS
FHIR
7b. Sponsoring WG Approval Date
May 23, 2019
7c. Co-Sponsor Approval Date
May 23, 2019
7c. Co-Sponsor 2 Approval Date
May 28, 2019
7c. Co-Sponsor 3 Approval Date
May 23, 2019
7c. Co-Sponsor 4 Approval Date
7c. Co-Sponsor 5 Approval Date
7c. Co-Sponsor 6 Approval Date
7c. Co-Sponsor 7 Approval Date
7c. Co-Sponsor 8 Approval Date
7c. Co-Sponsor 9 Approval Date
7c. Co-Sponsor 10 Approval Date
7e. CDA MG Approval Date
7f. FMG Approval Date
Nov 13, 2019
7g. V2 MG Approval Date
7h. Architecture Review Board Approval Date
7i. Steering Division Approval Date
Mar 09, 2020
7j. TSC Approval Date
Mar 16, 2020
 Show Changes
Version
2
Modifier
Susan Matney
Modify Date
Jan 25, 2021 22:04
1a. Project Name
Skin and Wound Assessment PSS
1b. Project ID
1584
1c. Is Your Project an Investigative Project (aka PSS-Lite)?
No
1d. Is your Project Artifact now proceeding to Normative directly or after being either Informative or STU?
No
2a. Primary/Sponsor WG
Patient Care
2b. Co-Sponsor WG
Clinical Information Modeling Initiative
2c. Co-Sponsor Level of Involvement
Request formal content review prior to ballot
2b. Co-Sponsor WG 2
Electronic Health Record
2c. Co-Sponsor Level of Involvement
Request periodic project updates; specify period in text box below (e.g. 'Monthly', 'At WGMs', etc.)
2c. Co-Sponsor 2 Update Periods
Weekly as appropriate
2c. Co-Sponsor Level of Involvement
Request periodic project updates; specify period in text box below (e.g. 'Monthly', 'At WGMs', etc.)
2d. Project Facilitator
Susan Matney
2e. Other Interested Parties (and roles)
Michael Brody, DPM. CEO Registry Clearinghouse
2f. Modeling Facilitator
Nathan Davis
2g. Publishing Facilitator
Patrick Langford
2h. Vocabulary Facilitator
Susan Matney
2i. Domain Expert Representative
National Pressure Ulcer Advisory Panel
2m. Implementers
Tissue Analytics
Intermountain Heatlhcare
3a. Project Scope
To develop a skin and wound assessment model and FHIR profiles which can be used to document, track and trend wound care across settings.
This FHIR implementation guide will use the US Core profiles. If this FHIR implementation guide is unable to use a US Core profile we will request approval from US Realm SC, and provide the US Realm approved rationale for deviation in the implementation guide where applicable.
3b. Project Need
Wound care is a clinical domain of high interest because iatrogenic skin and tissue breakdowns (e.g., pressure ulcers) and the mitigation of risk for skin breakdown are recognized as indicators of quality. The National Quality Forum endorsed pressure ulcers as a nursing sensitive outcome measure, and the Centers for Medicare and Medicaid Services (CMS) view hospital acquired pressure ulcers as a preventable hospital acquired condition for which hospitals no longer receive added reimbursement.
Wounds are also cared for across settings. Wounds are documented in three different apps within Intermountain Healthcare, one of which is Tissue Analytics - therefore, Intermountain would like to implement the FHIR profiles within their enterprise.
3c. Security Risk
No
3d. External Drivers
Veteran's Administration, National Pressure Ulcer Advisory Panel, Podiatrists
3e. Objectives/Deliverables and Target Dates
1. Develop the logical model (complete)
2. Curate the needed terminology content with LOINC and SNOMED CT (complete).
3. Test the FHIR profiles during a connectathon (Done in Montreal)
4. Create R4 FHIR profiles and IG - first draft done 1/31/2020
5. Enhance FHIR profile for implementers, including expanding body locations (in progress, target is 3/15/2020).
6. Develop the IG (target date 3/28/2020)
7. Connectathon - May 2021
8. Ballot in Sept 2021
4b. For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to?
v4
5a. Project Intent
Create new standard
5b. Project Ballot Type
STU to Normative
5c. Additional Ballot Info
https://github.com/HL7/fhir-skin-wound-ig
5d. Joint Copyright
Yes
5e. I understand I must submit a Joint Copyright Letter of Agreement to the TSC in order for the PSS to receive TSC approval.
Yes
6a. External Project Collaboration
National Pressure Ulcer Advisory Panel
Wound care nurses at the Veteran's administration as subject matter experts.
6b. Content Already Developed
90
6c. Content externally developed?
No
6d. List Developers of Externally Developed Content
Nursing Knowledge Big Data Science Initiative
Solor content developers (Keith Campbell, Susan Matney, et al.)
Intermountain Healthcare
Podiatrists
6e. Is this a hosted (externally funded) project?
No
6f. Stakeholders
Quality Reporting Agencies, Regulatory Agency, Standards Development Organizations (SDOs), Payors
6g. Vendors
EHR, PHR
6h. Providers
Emergency Services, Healthcare Institutions (hospitals, long term care, home care, mental health)
6i. Realm
U.S. Realm Specific
7a. Management Group(s) to Review PSS
FHIR
7b. Sponsoring WG Approval Date
May 23, 2019
7c. Co-Sponsor Approval Date
May 23, 2019
7c. Co-Sponsor 2 Approval Date
May 28, 2019
7c. Co-Sponsor 3 Approval Date
May 23, 2019
7d. US Realm Approval Date
Feb 25, 2020
7f. FMG Approval Date
Nov 13, 2019
7i. Steering Division Approval Date
Mar 09, 2020
7j. TSC Approval Date
Mar 16, 2020
Version
1
Modifier
Lynn Laakso
Modify Date
Nov 13, 2019 19:07
1a. Project Name
Skin and Wound Assessment PSS
1b. Project ID
1584
1c. Is Your Project an Investigative Project (aka PSS-Lite)?
No
1d. Is your Project Artifact now proceeding to Normative directly or after being either Informative or STU?
No
2a. Primary/Sponsor WG
Patient Care
2b. Co-Sponsor WG
Clinical Information Modeling Initiative
2c. Co-Sponsor Level of Involvement
Request formal content review prior to ballot
2b. Co-Sponsor WG 2
Electronic Health Record
2c. Co-Sponsor Level of Involvement
Request periodic project updates; specify period in text box below (e.g. 'Monthly', 'At WGMs', etc.)
2c. Co-Sponsor 2 Update Periods
Weekly as appropriate
2c. Co-Sponsor Level of Involvement
Request periodic project updates; specify period in text box below (e.g. 'Monthly', 'At WGMs', etc.)
2d. Project Facilitator
Susan Matney
2e. Other Interested Parties (and roles)
Michael Brody, DPM. CEO Registry Clearinghouse
2f. Modeling Facilitator
Nathan Davis
2h. Vocabulary Facilitator
Susan Matney
2i. Domain Expert Representative
National Pressure Ulcer Advisory Panel
2m. Implementers
Podiatry group
Tissue Analytics
Intermountain Heatlhcare
3a. Project Scope
To develop a skin and wound assessment model and FHIR profiles which can be used to document, track and trend wound care across settings.
3b. Project Need
Wound care is a clinical domain of high interest because iatrogenic skin and tissue breakdowns (e.g., pressure ulcers) and the mitigation of risk for skin breakdown are recognized as indicators of quality. The National Quality Forum endorsed pressure ulcers as a nursing sensitive outcome measure, and the Centers for Medicare and Medicaid Services (CMS) view hospital acquired pressure ulcers as a preventable hospital acquired condition for which hospitals no longer receive added reimbursement.
Wounds are also cared for across settings. Wounds are documented in three different apps within Intermountain Healthcare, one of which is Tissue Analytics - therefore, Intermountain would like to implement the FHIR profiles within their enterprise.
3c. Security Risk
No
3d. External Drivers
Veteran's Administration, National Pressure Ulcer Advisory Panel, Podiatrists
3e. Objectives/Deliverables and Target Dates
1. Develop the logical model (complete)
2. Curate the needed terminology content with LOINC and SNOMED CT (complete).
3. Develop the FHIR profiles (R3) (complete)
4. Test the FHIR profiles during a connectathon (Done in Montreal)
5. Convert to R4 FHIR profiles
6. Enhance FHIR profile for implementers, including expanding body locations (in progress, target is 9/30/2019).
7. Develop the IG
8. Collaborate with implementers FHIR enable their applications (no set date yet).
9. Pilot test
10. Ballot in January 2020